These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 16636125)

  • 1. Genetic variation in the visfatin gene (PBEF1) and its relation to glucose metabolism and fat-depot-specific messenger ribonucleic acid expression in humans.
    Böttcher Y; Teupser D; Enigk B; Berndt J; Klöting N; Schön MR; Thiery J; Blüher M; Stumvoll M; Kovacs P
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2725-31. PubMed ID: 16636125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of genetic variation in the visfatin gene (PBEF1) on obesity, glucose metabolism, and blood pressure in children.
    Körner A; Böttcher Y; Enigk B; Kiess W; Stumvoll M; Kovacs P
    Metabolism; 2007 Jun; 56(6):772-7. PubMed ID: 17512309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans.
    Berndt J; Klöting N; Kralisch S; Kovacs P; Fasshauer M; Schön MR; Stumvoll M; Blüher M
    Diabetes; 2005 Oct; 54(10):2911-6. PubMed ID: 16186392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The visfatin (PBEF1) G-948T gene polymorphism is associated with increased high-density lipoprotein cholesterol in obese subjects.
    Johansson LM; Johansson LE; Ridderstråle M
    Metabolism; 2008 Nov; 57(11):1558-62. PubMed ID: 18940394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visfatin and its genetic variants are associated with obesity-related morbidities and cardiometabolic risk in severely obese children.
    Ooi SQ; Chan RM; Poh LK; Loke KY; Heng CK; Chan YH; Gan SU; Lee KO; Lee YS
    Pediatr Obes; 2014 Apr; 9(2):81-91. PubMed ID: 23447513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans.
    Pagano C; Pilon C; Olivieri M; Mason P; Fabris R; Serra R; Milan G; Rossato M; Federspil G; Vettor R
    J Clin Endocrinol Metab; 2006 Aug; 91(8):3165-70. PubMed ID: 16720654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variation in the visfatin (PBEF1/NAMPT) gene and type 2 diabetes in the Greek population.
    Paschou P; Kukuvitis A; Yavropoulou MP; Dritsoula A; Giapoutzidis V; Anastasiou O; Kazakos K; Yovos JG
    Cytokine; 2010 Jul; 51(1):25-7. PubMed ID: 20451405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common polymorphisms in the promoter of the visfatin gene (PBEF1) influence plasma insulin levels in a French-Canadian population.
    Bailey SD; Loredo-Osti JC; Lepage P; Faith J; Fontaine J; Desbiens KM; Hudson TJ; Bouchard C; Gaudet D; Pérusse L; Vohl MC; Engert JC
    Diabetes; 2006 Oct; 55(10):2896-902. PubMed ID: 17003359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of genetic variation in the human fatty acid synthase gene (FASN) on obesity and fat depot-specific mRNA expression.
    Schleinitz D; Klöting N; Körner A; Berndt J; Reichenbächer M; Tönjes A; Ruschke K; Böttcher Y; Dietrich K; Enigk B; Filz M; Schön MR; Jenkner J; Kiess W; Stumvoll M; Blüher M; Kovacs P
    Obesity (Silver Spring); 2010 Jun; 18(6):1218-25. PubMed ID: 19876008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A visfatin promoter polymorphism is associated with low-grade inflammation and type 2 diabetes.
    Zhang YY; Gottardo L; Thompson R; Powers C; Nolan D; Duffy J; Marescotti MC; Avogaro A; Doria A
    Obesity (Silver Spring); 2006 Dec; 14(12):2119-26. PubMed ID: 17189536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of genetic variation in the human retinol binding protein-4 gene (RBP4) on insulin resistance and fat depot-specific mRNA expression.
    Kovacs P; Geyer M; Berndt J; Klöting N; Graham TE; Böttcher Y; Enigk B; Tönjes A; Schleinitz D; Schön MR; Kahn BB; Blüher M; Stumvoll M
    Diabetes; 2007 Dec; 56(12):3095-100. PubMed ID: 17728376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and Cardiovascular Risk: Variations in Visfatin Gene Can Modify the Obesity Associated Cardiovascular Risk. Results from the Segovia Population Based-Study. Spain.
    Martínez Larrad MT; Corbatón Anchuelo A; Fernández Pérez C; Pérez Barba M; Lazcano Redondo Y; Serrano Ríos M;
    PLoS One; 2016; 11(5):e0153976. PubMed ID: 27166797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The visfatin gene is associated with glucose and lipid metabolism in a Chinese population.
    Jian WX; Luo TH; Gu YY; Zhang HL; Zheng S; Dai M; Han JF; Zhao Y; Li G; Luo M
    Diabet Med; 2006 Sep; 23(9):967-73. PubMed ID: 16922702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus.
    Chen MP; Chung FM; Chang DM; Tsai JC; Huang HF; Shin SJ; Lee YJ
    J Clin Endocrinol Metab; 2006 Jan; 91(1):295-9. PubMed ID: 16234302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating visfatin is associated with parameters of iron metabolism in subjects with altered glucose tolerance.
    Fernández-Real JM; Moreno JM; Chico B; López-Bermejo A; Ricart W
    Diabetes Care; 2007 Mar; 30(3):616-21. PubMed ID: 17327330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats.
    Choi KC; Ryu OH; Lee KW; Kim HY; Seo JA; Kim SG; Kim NH; Choi DS; Baik SH; Choi KM
    Biochem Biophys Res Commun; 2005 Oct; 336(3):747-53. PubMed ID: 16157299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum visfatin in relation to visceral fat, obesity, and type 2 diabetes mellitus in Asian Indians.
    Sandeep S; Velmurugan K; Deepa R; Mohan V
    Metabolism; 2007 Apr; 56(4):565-70. PubMed ID: 17379018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes.
    Klöting N; Berndt J; Kralisch S; Kovacs P; Fasshauer M; Schön MR; Stumvoll M; Blüher M
    Biochem Biophys Res Commun; 2006 Jan; 339(1):430-6. PubMed ID: 16298335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association between both resistin, visfatin and insulin resistance as well as β cell function in the first-degree relatives of type 2 diabetes mellitus].
    Zhang XJ; Wang Z; Li HH; Yu L; Gao S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Dec; 31(12):1393-6. PubMed ID: 21223671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship of visfatin/pre-B-cell colony-enhancing factor/nicotinamide phosphoribosyltransferase in adipose tissue with inflammation, insulin resistance, and plasma lipids.
    Chang YC; Chang TJ; Lee WJ; Chuang LM
    Metabolism; 2010 Jan; 59(1):93-9. PubMed ID: 19765775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.